| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.009 |